Obstetrics/Gynecology
RSSArticles
-
What You Can't See Will Hurt You (and Your Patient)
Concealed renal insufficiency is common and contributes to adverse drug reactions from hydrosoluble medications. -
Full June 15, 2005, Issue in PDF
-
Pharmacology Watch: Is Nesiritide Associated with a Higher Death Rate?
Nesiritide, Scios' intravenous recombinant form of human B-type naturetic peptide, has been widely used for the treatment of congestive heart failure in hospitalized patients. That may change with the publication of a new study that suggests that patients with acutely decompensated heart failure treated with nesiritide have a higher death rate at 30 days compared with patients who are not treated with the drug. -
ECG Review: Too Irregular for VT?
The lead II rhythm strip shown in the Figure was obtained from an older man with ischemic cardiomyopathy. This asymptomatic 10-beat run of anomalous complexes was felt to be too irregular for VT (ventricular tachycardia). Do you agree? -
Clinical Briefs
Because many of the clinical consequences of hemochromatosis are able to be reversed, or at least halted by appropriate treatment (phlebotomy), it is important to heighten clinician awareness of the disorder. -
Full July 22, 2002, Issue in PDF
-
Management of Migraine: Part I
-
ECG Review: Bigeminal Term Misuse
-
Full August 15, 2002, Issue in PDF
-
Pharmacology Watch: No Shortage in Sight for Tetanus-Diphtheria Vaccine